Clinical Study Results
How has the study helped patients and
researchers?
The results presented here are for a single study in healthy male participants. These
results helped the researchers learn about how safe it was to take AZD4831 for
participants in the study.
Researchers look at the results of many studies to decide which treatments
work best and are safest. Other studies may provide new information or different
results. Always talk to a doctor before making any treatment changes.
Further clinical studies with AZD4831 are planned.
Where can I learn more about the study?
You can find more information about the study on the website listed below.
If a full report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03136991”
into the search box and click “Search”.
Full study title: A Phase I, Randomized, Single-blind, Placebo-controlled Study
to Assess the Safety, Tolerability and Pharmacokinetics of AZD4831 after Multiple
Ascending Dose Administration to Healthy Male Subjects
AstraZeneca protocol number: D6580C00004
AstraZeneca AB sponsored this study and has its headquarters in
Södertälje, Sweden.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part
in clinical research around the world. They help researchers answer important
health questions and find medical treatments for participants.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 510 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
6
Version: v2.0 11/2018